[Federal Register Volume 60, Number 191 (Tuesday, October 3, 1995)]
[Notices]
[Page 51802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-24533]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Advisory Committee Meeting; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of meeting of the Food Advisory Committee. This 
meeting was announced in the Federal Register of September 26, 1995 (60 
FR 49616). Persons planning to attend and/or planning to make a formal 
presentation were asked to notify the contact person by close of 
business September 29, 1995. This document extends that date to close 
of business October 5, 1995. There are no other changes.

FOR FURTHER INFORMATION CONTACT:
     Lynn A. Larsen, Center for Food Safety and Applied Nutrition -
(HFS-5), Food and Drug Administration, 200 C St. SW., Washington, DC 
20204, 202-205-4727, or
    Catherine M. DeRoever, Advisory Committee Staff (HFS-22), Food and 
Drug Administration, 200 C St. SW., Washington, DC 20204, 202-205-4251, 
or
    FDA Advisory Committee Information Hotline, 1-800-741-8138 (301-
443-0572 in the Washington, DC area), Food Advisory Committee, code 
10564.
SUPPLEMENTARY INFORMATION: In the Federal Register of September 26, 
1995, FDA announced a meeting of Food Advisory Committee. Beginning on 
page 49616, column 3, the ``Agenda--Open public hearing'' portion of 
this meeting is amended to read as follows:
    Agenda--Open public hearing. Interested persons may present data, 
information , or views, orally or in writing, on issues pending before 
the committee. Those desiring to make formal presentations should 
notify the contact person by close of business October 5, 1995, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time required to 
make their comments. If necessary, comments may be limited to 5 
minutes.

    Dated: September 27, 1995.
 David A. Kessler,
 Commissioner of Food and Drugs.
[FR Doc. 95-24533 Filed 9-28-95; 11:22 am]
BILLING CODE 4160-01-F